These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 1009528)
1. Further experience with isophosphamide. Falkson G; Falkson HC Cancer Treat Rep; 1976 Jul; 60(7):955-7. PubMed ID: 1009528 [No Abstract] [Full Text] [Related]
2. [1st clinical experiences with isophosphamide. Long-term results of 2 therapeutic approaches]. Pigatto JC Prensa Med Argent; 1971 Oct; 58(32):1618-21. PubMed ID: 4943249 [No Abstract] [Full Text] [Related]
3. [Results of a cyclophosphamide therapy in genital and mammary carcinomas]. Naumann R Zentralbl Gynakol; 1970 May; 92(22):700-2. PubMed ID: 5284155 [No Abstract] [Full Text] [Related]
4. [Experience with cyclophosphamide treatment over 10 years in a general medicine ward]. Laursen MW Nord Med; 1971 Apr; 85(16):503. PubMed ID: 5103296 [No Abstract] [Full Text] [Related]
5. [Use of large single doses of cyclophosphane (endoxan)]. Garin AM Vopr Onkol; 1970; 16(11):43-8. PubMed ID: 4929048 [No Abstract] [Full Text] [Related]
6. The anticancer spectrum of ifosfamide. Hunter HL; Harrison EF Semin Oncol; 1982 Dec; 9(4 Suppl 1):96-100. PubMed ID: 6761868 [No Abstract] [Full Text] [Related]
7. Ifosfamide--pharmacology, safety and therapeutic potential. Brade WP; Herdrich K; Varini M Cancer Treat Rev; 1985 Mar; 12(1):1-47. PubMed ID: 3896483 [No Abstract] [Full Text] [Related]
17. Heterogeneity of drug resistance in human breast and ovarian cancers. Kern DH Cancer J Sci Am; 1998; 4(1):41-5. PubMed ID: 9467045 [TBL] [Abstract][Full Text] [Related]
18. [Anticancer treatment and bromelains]. Gerard G Agressologie; 1972; 13(4):261-74. PubMed ID: 4678520 [No Abstract] [Full Text] [Related]
19. [Treatment with large doses of cyclophosphamide of breast cancer with metastases to solid viscera]. Chrapowicki A Wiad Lek; 1971 Dec; 24(24):2323-6. PubMed ID: 5139720 [No Abstract] [Full Text] [Related]
20. A case-control study of leukaemia as a second primary malignancy following ovarian and breast neoplasms. Mehnert WH; Haas JF; Kittelmann B; Staneczek W; Möhner M; Kaldor JM; Day NE IARC Sci Publ; 1986; (78):203-21. PubMed ID: 3583391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]